Medicamen Biotech Ltd share price logo

Medicamen Biotech Ltd

NSE: MEDICAMEQ

BSE: 531146

Small Cap

Pharma Sector

₹223.50

-22.15

(-9.02%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Medicamen Biotech Stock Performance

as on June 8, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹218.00
    ₹248.70
    downward going graph

    2.46%

    Downside

    11.28%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹216.95
    ₹448.80
    downward going graph

    2.93%

    Downside

    100.81%

    Upside

    downward going graph

Medicamen Biotech share price movements today

Previous Close
₹245.65
Open
₹245.10
Volume
47.12K
Upper Circuit
₹294.75
Lower Circuit
₹196.55
Day's Low - High
₹218.00 - ₹248.70
52 Week Low - High
₹216.95 - ₹448.80

Medicamen Biotech Historical Returns

1 Month Return
-16.53 %
3 Month Return
-14.29 %
1 Year Return
-41.75 %
3 Year Return
-63.48 %
5 Year Return
-55.5 %

Medicamen Biotech Fundamentals

as on June 8, 2026 at 4:01 pm IST

Market Cap

₹333.17 Cr

Return on Equity (ROE)

4.43

PE Ratio (TTM)

33.98

Return on capital employed (ROCE)

6.71

Industry PE ratio

46.11

Beta (LTM)

1

P/B Ratio

2.81

Dividend Yield

0.21

PEG Ratio

16.03

Quarterly Earnings Growth YOY

139.25

EPS (TTM)

5.16

Book Value

167.57

Medicamen Biotech Stock Valuation

as on June 8, 2026 at 4:01 pm IST

Medicamen Biotech in the last 5 years

  • Overview

  • Trends

Lowest (31.20x)

April 7, 2026

Today (33.98x)

June 5, 2026

Industry (46.11x)

June 5, 2026

Highest (132.87x)

December 6, 2024

LowHigh

Today’s Price to Earnings Ratio: 33.98x

Medicamen Biotech Technical Analysis

Track how Medicamen Biotech technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish13
Bullish1
Neutral1

Oscillators

Name

Value

Action

MACD level (12,26)
-2.36
Bearish
CCI (20)
196.15
Bearish
RSI (14)
32.74
Neutral
Momentum (10)
-1.55
Bullish
ADI (14)
44.22
Bearish
Ultimate Oscillator (7,14,28)
14.98
Bearish

Moving Averages

Name

Value

Action

SMA (20)
223.91
Bearish
EMA (20)
224.04
Bearish
VWMA (20)
223.06
Bearish
SMA (50)
228.28
Bearish
EMA (50)
228.05
Bearish
SMA (200)
237.03
Bearish
EMA (200)
235.91
Bearish
KAMA (200)
224.57
Bearish
DEMA (200)
230.02
Bearish

Medicamen Biotech Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Medicamen Biotech with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Medicamen Biotech Ltd image
Medicamen Biotech Ltd
NA333.17-11.1%0.576162
Parmax Pharma Ltd image
Parmax Pharma Ltd
NA17.11-5.28%0.00-328
Beryl Drugs Ltd image
Beryl Drugs Ltd
NA11.5831.97%0.00-121
Aarti Pharmalabs Ltd image
Aarti Pharmalabs Ltd
HOLD5,696.0323.59%0.592722,115
Bajaj Healthcare Ltd image
Bajaj Healthcare Ltd
NA988.00-3.83%0.0039542
See all

Medicamen Biotech Stock’s Investor Sentiment and Interest

Search interest for Medicamen Biotech Ltd Stock has decreased by -39% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-39% versus previous 30 day period

Medicamen Biotech Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
41.94
43.54
46.5
47.32
43.05
44.74
45.14
29.61
43.04
47.17
46.91
60.65
Other Income
0.38
0.55
0.83
0.57
0.59
0.29
0.14
5.23
0.47
0.37
0.53
1.74
Total Income
42.32
44.09
47.33
47.89
43.63
45.03
45.28
34.84
43.52
47.54
47.44
62.38
Expenses
34.99
38.9
41.61
41.57
39.6
39.43
38.44
31.22
38.43
42.01
42.53
55.21
Operating Profit
6.95
4.64
4.89
5.75
3.45
5.31
6.7
-1.61
4.61
5.16
4.38
5.44
Operating Profit Margin %
16.57%
10.66%
10.52%
12.15%
8.01%
11.87%
14.84%
-5.44%
10.71%
10.94%
9.34%
8.97%
Profit Before Interest, Tax and Depreciation
7.33
5.19
5.72
6.32
4.03
5.6
6.85
3.62
5.09
5.53
4.91
7.18
Interest
0.96
0.91
0.65
1.89
0.71
1.04
0.76
0.65
1.15
0.99
0.97
0.38
Depreciation
1.69
1.82
1.8
1.77
1.77
2.61
2.21
0.48
1.8
1.86
1.83
1.73
Profit Before Tax
4.68
2.46
3.27
2.66
1.55
1.95
3.88
2.49
2.14
2.68
2.11
5.07
Tax Paid
0.74
0.98
1.25
0.61
0.76
1.05
0.96
0.63
0.53
0.57
0.47
0.61
Profit After Tax
3.95
1.48
2.03
2.04
0.8
0.9
2.92
1.86
1.6
2.11
1.63
4.45
Total Net profit including share of profit / Loss from associate company
3.95
1.48
2.03
2.04
0.8
0.9
2.92
1.86
1.6
2.11
1.63
4.45
EPS
3.12
1.17
1.6
1.61
0.63
0.71
2.3
1.47
1.18
1.56
1.21
3.28
Actual EPS
3.12
1.17
1.6
1.61
0.63
0.71
2.3
1.47
1.18
1.56
1.21
3.28
Adjusted EPS
3.12
1.17
1.6
1.61
0.63
0.71
2.3
1.47
1.18
1.56
1.21
3.28
Diluted EPS
3.12
1.17
1.6
1.61
0.63
0.71
2.3
1.47
1.18
1.56
1.21
3.28

Medicamen Biotech Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
122.6
125.5
112.72
115.45
140.87
179.31
162.55
197.77
Other Income
3.66
1.94
0.75
1.72
2.46
2.33
6.24
3.11
Total Income
126.26
127.44
113.47
117.17
143.33
181.63
168.79
200.88
Expenses
105.59
106.39
93.49
91.9
117
157.07
148.69
178.18
Operating Profit
17.01
19.11
19.23
23.55
23.87
22.24
13.86
19.59
Operating Profit Margin %
13.87%
15.23%
17.06%
20.4%
16.94%
12.4%
8.53%
9.91%
Profit Before Interest, Tax and Depreciation
20.67
21.05
19.98
25.27
26.33
24.57
20.1
22.7
Interest
0.94
0.57
1.06
1.4
2.92
4.4
3.16
3.5
Depreciation
2.21
2.5
2.52
5.77
6.37
7.09
7.07
7.22
Profit Before Tax
17.52
17.98
16.4
18.1
17.04
13.08
9.87
11.98
Tax Paid
5.5
4.69
4.27
3.2
2.32
3.58
3.32
2.19
Profit After Tax
12.03
13.29
12.13
14.9
14.73
9.49
6.56
9.8
Total Net profit including share of profit / Loss from associate company
12.03
13.29
12.13
14.9
14.73
9.49
6.56
9.8
EPS
10.28
10.94
9.93
12.19
11.82
7.5
5.16
7.22
Actual EPS
10.28
10.94
9.93
12.19
11.82
7.5
5.16
7.22
Adjusted EPS
10.28
10.94
9.93
12.19
11.82
7.5
5.16
7.22
Diluted EPS
10.28
10.94
9.93
12.19
11.82
7.5
5.16
7.22

Medicamen Biotech Ltd Cash Flow

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
4.3
12.8
12.77
4.11
-6.29
-6.74
-8.16
Cash Flow from Investing Activities
-14.76
-37.29
-17.82
-8.47
-5.88
-5.57
-1.4
Cash Flow from Financing Activities
-3.69
19.07
5.84
4.3
29.13
6.31
-1.47
Net Cash Flow
-14.15
-5.43
0.8
-0.07
16.95
-5.99
-11.03

Medicamen Biotech Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Apr 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
43.21%
43.21%
43.21%
42.99%
42.99%
42.99%
43.16%
40.46%
40.46%
40.46%
40.46%
40.46%
DII
0%
0.68%
0.99%
1.17%
1.17%
0.87%
0.69%
0.65%
0.64%
0.59%
0.44%
0%
FII
0%
0.21%
0.11%
0.06%
0.06%
0.05%
0.12%
0.22%
0%
0.06%
0.02%
0.1%
Government
0%
0%
0%
0%
0%
0.06%
0.06%
0.05%
0.05%
0.05%
0.05%
0.05%
Public
56.38%
55.9%
55.69%
55.78%
55.77%
56.04%
55.98%
58.62%
58.84%
58.85%
59.03%
59.39%
Total Outstanding Shares
1,26,51,100
1,26,51,100
1,26,51,100
1,27,14,600
1,27,14,600
1,27,14,600
1,27,14,600
1,35,62,815
1,35,62,815
1,35,62,815
1,35,62,815
1,35,62,815
Total Shareholders
9,419
10,252
10,639
10,652
10,792
10,576
10,435
10,592
10,808
11,177
10,967
10,806

Medicamen Biotech Corporate Actions

View detailed summary of the earnings and dividend history of Medicamen Biotech.

  • Medicamen Biotech Ltd Earnings Results

    Medicamen Biotech Ltd’s net profit jumped 59.5% since last year same period to ₹3.86Cr in the Q4 2025-2026. On a quarterly growth basis, Medicamen Biotech Ltd has generated 76.26% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Medicamen Biotech Ltd Dividends May,2025

    In the quarter ending March 2025, Medicamen Biotech Ltd has declared dividend of ₹1.00 per share on 30 May 2025 - translating a dividend yield of 0.41%.

    Read More about Dividends

Insights on Medicamen Biotech Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 59.03% to 59.39% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.02% to 0.10% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 2.19 Cr → 3.86 Cr (in ₹), with an average increase of 43.3% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 47.44 Cr → 62.38 Cr (in ₹), with an average increase of 24.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 39.0% return, outperforming this stock by 80.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 145.9% return, outperforming this stock by 209.4%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 40.46% of holdings in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, MEDICAMEQ stock has moved down by -9.1%

About Medicamen Biotech Ltd

Medicamen Biotech Ltd. is a globally recognized public limited company involved in the manufacturing and selling of pharmaceutical products in overseas and domestic markets. It has two ultra modern manufacturing facilities in Bhiwadi (Rajasthan) and Haridwar (Uttarakhand) equipped with the latest state of the art technology, manned by qualified personnel and hardworking workforce. In 2005, the second unit was installed in the tax-free zone in Haridwar with a facility to produce Non Betalactum tablets, capsules, oral liquids, and ointments. In 2009, the company added analgesic, antibiotics and Antifilarial/TB drugs and started supplying bulk Anti-bacterial products like Cotrimoxazole to foreign partners. The company has been recognized for its commitment to provide quality medicines at competitive prices whilst also being socially responsible. In 2015, Shivalik Rasayan acquired 44.15% of the paid-up equity share capital of the Company. The company acquired 100% stake of OPAL Pharmaceuticals in 2019-20 and merged with the same. In January 2022, 12 Oncology products were launched in the domestic market. Overall, the company has been focusing on delivering quality products to overseas and domestic customers since 1993 through cost-effective manufacturing and distribution.

Revenue: ₹60.65Cr as on March 2026 (Q4 FY26)
Net Profit: ₹4.45Cr as on March 2026 (Q4 FY26)
Listing date: 27 Oct, 2021
Chairperson Name: Rahul Bishnoi
OrganisationMedicamen Biotech Ltd
IndustryPharmaceuticals
CEORahul Bishnoi
E-voting on sharesClick here to vote

FAQs

What is Medicamen Biotech share price today?

Medicamen Biotech share price today stands at ₹223.5 as on at the close of the market. Medicamen Biotech share today touched a day high of ₹248.7 and a low of ₹218.

What is the 52 week high and 52 week low range for Medicamen Biotech share?

Medicamen Biotech touched a 52 week high of ₹448.8 and a 52 week low of ₹216.95. Medicamen Biotech share price today i.e. is closed at ₹223.5, which is -50.20% down from its 52 week high and 3.02% up from its 52 week low.

What is Medicamen Biotech's market capitalisation today?

Medicamen Biotech market capitalisation is ₹333.17 Cr as on .

How to buy Medicamen Biotech shares?

To buy Medicamen Biotech shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for MEDICAMEQ or Medicamen Biotech Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Medicamen Biotech shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Medicamen Biotech trading volume today?

Medicamen Biotech trading volume is 47.12K as on . This means that 47.12K shares of Medicamen Biotech were bought and sold on the stock market during today's trading session.